美股异动丨Viking Therapeutics大涨超15%,计划推进口服减肥药后期测试

格隆汇
Feb 12

药物开发商Viking Therapeutics(VKTX.US)大涨超15%,报32.9美元。消息面上,Viking Therapeutics计划于今年第三季度将其试验性减肥药VK2735的片剂推进到后期研究阶段。中期研究数据显示,通过低剂量口服治疗策略可以有效维持体重。(格隆汇)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10